MET F/SVs but not genomic amplification, were highly enriched in the secondary glioblastomas (sGBM) and marked worse prognosis. Further molecular and scRNA-seq analysis revealed that…

Data Prevalence is defining co-founder in statistics. Thanks for your visit Dr. Klimova from NCT partner site Dresden.

November 2022: Invited talk at NOA Annual Meeting in Kopfklinik University Medical Center Heidelberg. Interesting to learn about the Alcatraz concept of cancer therapy.

October 2022: Invited talk Nano2Clinic Final conference @ La Sapienza, Rome. Great progress towards position paper on innovation for future drug development and new COST…

New publication with participation of our team on the transcription factor ZEB1 and its potential as therapeutic target in neuroinflammatory diseases.

New publication from your team on Collagen 10 type A1 and its relevance as clinical predictive marker in colon cancer.